Extreme weather events driven by climate change have profound consequences for the sexual and reproductive health of young refugees in Uganda, according to a new study published last month in Global Public Health.

A study led by CIC bioGUNE, recently published in npj Genomic Medicine, demonstrates that integrating multi-omic data (genomic, metabolomic, and lipoproteomic) can identify hidden disease risks in healthy individuals. Conducted with a Basque Country cohort of 162 people, the research uncovered four distinct molecular profiles, one of which (cluster C4) showed a stable, silent risk for cardiovascular issues, such as elevated triglycerides and low HDL cholesterol, over a two-year period. This pioneering approach emphasizes the potential of precision medicine and bioinformatics in predicting disease before symptoms arise, supporting a shift toward prevention-focused healthcare. The study also underlines the importance of using local populations for developing context-specific precision medicine strategies and reinforces Euskadi’s role in cutting-edge bioscience research.

A comparison of genetic data from all over the world specifies many general as well as a population-specific genetic predispositions for the neurogenerative disease Alzheimer’s. The results can lead to more precise and inclusive treatment options / publication in Nature Genetics

From the biology of aging to the future of artificial intelligence (AI)-driven medicine, Mount Sinai Health System will participate at the 2025 Aspen Ideas: Health (Sunday, June 22-Wednesday, June 25) and Aspen Ideas Festival (June 25-Tuesday, July 1) in Aspen, Colorado. Mount Sinai is proud to be a presenting underwriter of both festivals, where Mount Sinai thought leaders will lead discussions and the Health System will provide complimentary dermatologic screenings for attendees. “We return to Aspen Ideas: Health and the Aspen Ideas Festival deeply inspired—by the setting, the community, and the shared pursuit of progress,” said Brendan G. Carr, MD, MA, MS, Chief Executive Officer and the Kenneth L. Davis, MD, Distinguished Chair, Mount Sinai Health System. “This year, my colleagues will explore the emerging science of aging and inflammation and how Mount Sinai is harnessing AI to propel science and health care innovation. Our goal, as a learning health system, is to solve the world’s most complex health and science challenges to improve health of people everywhere.”